Design, synthesis and docking study of novel coumarin ligands as potential selective acetylcholinesterase inhibitors

References

• Ruiz PM, Rubio L, Palomero EG, et al. Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer’s disease. J Med Chem 2005;48:7223–33.
   PubMed Web of Science ®Google Scholar
• Bertram L, Tanzi RE. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 2008;9:768–78.
   PubMed Web of Science ®Google Scholar
• Holzgrabe U, Kapkova P, Alptuzun V, et al. Targeting acetylcholinesterase to treat neurodegeneration. Expert Opin Ther Targets 2007;11:161–79.
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Kalın P, Supuran CT, et al. The impact of hydroquinone on acetylcholine esterase and certain human carbonic anhydrase isoenzymes (hCA I, II, IX, and XII). J Enzyme Inhib Med Chem 2015;30:941–6.
   PubMed Web of Science ®Google Scholar
• Citron M. Strategies for disease modification in Alzheimer's disease. Nat Rev Neurosci 2004;5:677–85.
   PubMed Web of Science ®Google Scholar
• Gocer H, Akincioglu A, Goksu S, et al. Carbonic anhydrase and acetylcholinesterase inhibitory effects of carbamates and sulfamoylcarbamates. J Enzyme Inhib Med Chem 2015;30:316–20.
   PubMed Web of Science ®Google Scholar
• Pohanka M, Holas O. Evaluation of 2,6-dichlorophenolindophenol acetate as a substrate for acetylcholinesterase activity assay. J Enzyme Inhib Med Chem 2015;30:796–9.
   PubMed Web of Science ®Google Scholar
• Anand P, Singh B, Singh N. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease. Bioorg Med Chem 2012;20:1175–80.
   PubMed Web of Science ®Google Scholar
• Guillou C, Mary A, Renko DZ, et al. Potent acetylcholinesterase inhibitors: design, synthesis and structure-activity relationships of alkylene linked bis-galanthamine and galanthamine-galanthaminium salts. Bioorg Med Chem Lett 2000;10:637–9.
   PubMed Web of Science ®Google Scholar
• Camps P, el-Achab R, Gorbig DM, et al. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine a hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease. J Med Chem 1999;42:3227–42.
   PubMed Web of Science ®Google Scholar
• Pohanka M. Acetylcholinesterase inhibitors: a patent review (2008-present). Expert Opin Ther Pat 2012;22:871–86.
   PubMed Web of Science ®Google Scholar
• Leonetti F, Catto M, Nicolotti O, et al. Homo- and hetero-bivalent edrophonium-like ammonium salts as highly potent, dual binding site AChE inhibitors. Bioorg Med Chem 2008;16:7450–6.
   PubMed Web of Science ®Google Scholar
• Cheng Y, An LK, Wu N, et al. Synthesis, cytotoxic activities and structure-activity relationships of topoisomerase I inhibitors:indolizinoquinoline-5,12-dione derivatives. Bioorg Med Chem 2008;16:4617–25.
   PubMed Web of Science ®Google Scholar
• Torre P, Saavedra LA, Caballero J, et al. A Novel Class of Selective Acetylcholinesterase Inhibitors: Synthesis and Evaluation of (E)-2-(Benzo[d]thiazol-2-yl)-3-heteroarylacrylonitriles. Molecules 2012;17:12072–85.
   PubMed Web of Science ®Google Scholar
• Razavi SF, Khoobi M, Nadri H, et al. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors. Eur J Med Chem 2013;64:252–9.
   PubMed Web of Science ®Google Scholar
• Sussman JL, Harel M, Frolow F, et al. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 1991;253:872–9.
   PubMed Web of Science ®Google Scholar
• Mary A, Renko DZ, Guillou C, Thal C. Potent acetylcholinesterase inhibitors: Design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series. Bioorg Med Chem 1998;6:1835–50.
   PubMed Web of Science ®Google Scholar
• Asadipour A, Alipour M, Jafari M, et al. Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors. Eur J Med Chem 2013;70:623–30.
   PubMed Web of Science ®Google Scholar
• Wyman IW, Macartney DH. Host-Guest complexes and pseudorotaxanes of cucurbit[7]uril with acetylcholinesterase inhibitors. J Org Chem 2009;74:8031–8.
   PubMed Web of Science ®Google Scholar
• Mao F, Li J, Wei H, et al. Tacrine-propargylamine derivatives with improved acetylcholinesterase inhibitory activity and lower hepatotoxicity as a potential lead compound for the treatment of Alzheimer’s disease. J Enzyme Inhib Med Chem 2015;30:995–1001.
   PubMed Web of Science ®Google Scholar
• Bolognesi ML, Cavalli A, Valgimigli L, et al. Multi-Target-Directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against alzheimer’s disease. J Med Chem 2007;50:6446–9.
   PubMed Web of Science ®Google Scholar
• Tasso B, Catto M, Nicolotti O, et al. Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease. Eur J Med Chem 2011;46:2170–84.
   PubMed Web of Science ®Google Scholar
• Nam SO, Park DH, Lee YH, et al. Synthesis of aminoalkyl-substituted coumarin derivatives as acetylcholinesterase inhibitors. Bioorg Med Chem 2014;22:1262–7.
   PubMed Web of Science ®Google Scholar
• Kumar A, Gupta MH, Kumar M. An efficient non-ionic surfactant catalysed multicomponent synthesis of novel benzylamino coumarin derivative via Mannich type reaction in aqueous media. Tetrahedron Lett 2011;52:4521–5.
   Web of Science ®Google Scholar
• Parvez A, Meshram J, Tiwari V, et al. Pharmacophores modeling in terms of prediction of theoretical physico-chemical properties and verification by experimental correlations of novel coumarin derivatives produced via Betti’s protocol. Eur J Med Chem 2010;45:4370–8.
   PubMed Web of Science ®Google Scholar
• Piazzi L, Rampa A, Bisi A, et al. 3-(4-{[Benzyl(methyl)amino]-methyl}phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation: a dual function lead for Alzheimer's disease therapy. J Med Chem 2003;46:2279–82.
   PubMed Web of Science ®Google Scholar
• Mohamed T, Osman W, Tin G, Rao PPN. Selective inhibition of human acetylcholinesterase by xanthine derivatives: in vitro inhibition and molecular modelling investigations. Bioorg Med Chem Lett 2013;23:4336–41.
   PubMed Web of Science ®Google Scholar
• Kaboudin B, Arefi M, Emadi S, Hasani VS. Synthesis and inhibitory activity of ureidophosphonates, against acetylcholinesterase: pharmacological assay and molecular modelling. Bioorg Chem 2012;41–42:22–7.
   PubMed Web of Science ®Google Scholar
• Anand P, Singh B. Synthesis and evaluation of novel carbamate-substituted flavanone derivatives as potent acetylcholinesterase inhibitors and anti-amnestic agents. Med Chem Res 2013;22:1648–59.
   Web of Science ®Google Scholar
• Yılmaz S, Akbaba Y, Özgeriş B, et al. Synthesis and inhibitory properties of some carbamates on carbonic anhydrase and acetylcholine esterase. J Enzyme Inhib Med Chem 2016;31:1484–91.
   PubMed Web of Science ®Google Scholar
• Liu S, Shang R, Shi L, et al. Synthesis and biological evaluation of 7H-thiazolo[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors. Eur J Med Chem 2014;81:237–44.
   PubMed Web of Science ®Google Scholar
• Zengin-Kurt B, Gazioglu I, Basile L, et al. Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease. Eur J Med Chem 2015;102:80–92.
   PubMed Web of Science ®Google Scholar
• Zengin-Kurt B, Gazioglu I, Sonmez F, Kucukislamoglu M. Synthesis, antioxidant and anticholinesterase activities of novel coumarylthiazole derivatives. Bioorg Chem 2015;59:80–90.
   PubMed Web of Science ®Google Scholar
• Luo W, Su YB, Hong C, et al. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents. Bioorg Med Chem 2013;21:7275–82.
   PubMed Web of Science ®Google Scholar
• Thiratmatrakul S, Yenjai C, Waiwut P, et al. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease. Eur J Med Chem 2014;75:21–30.
   PubMed Web of Science ®Google Scholar
• Xie SS, Wang XB, Li JY, et al. Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer’s disease. Eur J Med Chem 2013;64:540–53.
   PubMed Web of Science ®Google Scholar
• Mjambili F, Njoroge M, Naran K, et al. Synthesis and biological evaluation of 2-aminothiazole derivatives as antimycobacterial and antiplasmodial agents. Bioorg Med Chem Lett 2014;24:560–4.
   PubMed Web of Science ®Google Scholar
• Huth JR, Song D, Mendoza RR, et al. Toxicological evaluation of thiol-reactive compounds identified using a la assay to detect reactive molecules by nuclear magnetic resonance. Chem Res Toxicol 2007;20:1752–9.
   PubMed Web of Science ®Google Scholar
• Devine SM, Mulcair MD, Debono CO, et al. Promiscuous 2-aminothiazoles (PrATs): a frequent hitting scaffold. J Med Chem 2015;58:1205–14.
   PubMed Web of Science ®Google Scholar
• Sugino T, Tanaka K. Solvent-Free coumarin synthesis. Chem Lett 2001;30:110–11.
   Web of Science ®Google Scholar
• Koelsch CF. Bromination of 3-acetocoumarin. J Am Chem Soc 1950;72:2993–5.
   Web of Science ®Google Scholar
• Hamama WS, Berghot MA, Baz EA, Gouda MA. Synthesis and antioxidant evaluation of some new 3-substituted coumarins. Arch Pharm 2011;344:710–18.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.
   PubMed Web of Science ®Google Scholar
• Xie SS, Wang X, Jiang N, et al. Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease. Eur J Med Chem 2015;95:153–65.
   PubMed Web of Science ®Google Scholar
• Meng FC, Mao F, Shan WJ, et al. Design, synthesis, and evaluation of indanone derivatives as acetylcholinesterase inhibitors and metal-chelating agents. Bioorg Med Chem Lett 2012;22:4462–6.
   PubMed Web of Science ®Google Scholar
• Karade NN, Gampawar SV, Shinde SV, Jadhav WN. L-Proline catalyzed solvent-free Knoevenagel condensation for the synthesis of 3-substituted coumarins. Chin J Chem 2007;25:1686–9.
   Web of Science ®Google Scholar
• Catto M, Pisani L, Leonetti F, et al. Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase. Bioorg Med Chem 2013;21:146–52.
   PubMed Web of Science ®Google Scholar
• Maresca A, Temperini C, Vu H, et al. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc 2009;131:3057–62.
   PubMed Web of Science ®Google Scholar
• Carta F, Maresca A, Scozzafava A, Supuran CT. Novel coumarins and 2-thioxo-coumarins as inhibitors of the tumor-associated carbonic anhydrases IX and XII. Bioorg Med Chem 2012;20:2266–79.
   PubMed Web of Science ®Google Scholar
• Karatas MO, Alici B, Cakir U, et al. Synthesis and carbonic anhydrase inhibitory properties of novel coumarin derivatives. J Enzyme Inhib Med Chem 2013;28:299–304.
   PubMed Web of Science ®Google Scholar
• Maresca A, Temperini C, Pochet L, et al. Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem 2010;53:335–44.
   PubMed Web of Science ®Google Scholar
• Maresca A, Scozzafava A, Supuran CT. 7,8-Disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range. Bioorg Med Chem Lett 2010;20:7255–8.
   PubMed Web of Science ®Google Scholar
• Zengin-Kurt B, Sonmez F, Gokce B, et al. In vitro inhibition effects on erythrocyte carbonic anhydrase I and II and structure-activity relationships of cumarylthiazole derivatives. Russian J Bioorg Chem 2016;42:506–11.
   Web of Science ®Google Scholar
• Turan B, Sendil K, Sengul E, et al. The synthesis of some β-lactams and investigation of their metal-chelating activity, carbonic anhydrase and acetylcholinesterase inhibition profiles. J Enzyme Inhib Med Chem 2016. [Epub ahead of print]. doi: 10.3109/14756366.2016.1170014.
   PubMed Web of Science ®Google Scholar
• Sujayev A, Garibov E, Taslimi P, et al. Synthesis of some tetrahydropyrimidine-5-carboxylates, determination of their metal chelating effects and inhibition profiles against acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase. J Enzyme Inhib Med Chem 2016;31:1531–9.
   PubMed Web of Science ®Google Scholar
• Ozgun DO, Yamali C, Gul HI, et al. Inhibitory effects of isatin Mannich bases on carbonic anhydrases, acetylcholinesterase, and butyrylcholinesterase. J Enzyme Inhib Med Chem 2016;31:1498–501.
   PubMed Web of Science ®Google Scholar
• Camps P, Formosa X, Galdeano C, et al. Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation. J Med Chem 2008;51:3588–98.
   PubMed Web of Science ®Google Scholar